Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P E Lipsky

Showing results (1-10 of 427) with videos related to

Pageof 43
Sort By:
The Journal of Rheumatology. Supplement|May 4, 1999
Specific COX-2 inhibitors in arthritis, oncology, and beyond: where is the science headed?P E Lipsky
Agents and Actions. Supplements|January 1, 1981
Modulation of T lymphocyte function by copper and thiolsP E Lipsky
American Journal of Orthopedics (Belle Mead, N.J.)|April 8, 1999
Role of cyclooxygenase-1 and -2 in health and diseaseP E Lipsky
Zeitschrift Fur Rheumatologie|January 1, 1988
Suggested mode of action of D-penicillamine as an immunosuppressive agent in rheumatoid arthritisP E Lipsky
The Journal of Rheumatology. Supplement|January 1, 1981
Modulation of human antibody production in vitro by D-penicillamine and CuSO4: inhibition of helper T cell functionP E Lipsky
Research in Immunology|May 1, 1990
The induction of human B-cell activation, proliferation and differentiation by anti-CD3-stimulated T cells--a model of T cell/B cell collaborationP E Lipsky
The Journal of Clinical Investigation|January 1, 1984
Immunosuppression by D-penicillamine in vitro. Inhibition of human T lymphocyte proliferation by copper- or ceruloplasmin-dependent generation of hydrogen peroxide and protection by monocytesP E Lipsky
Clinical and Experimental Rheumatology|September 1, 1989
Mechanisms of action of slow-acting drugs in rheumatoid arthritisP E Lipsky
Ryumachi. [Rheumatism]|December 1, 1987
Disease-modifying agents in rheumatoid arthritisP E Lipsky
Clinical and Experimental Rheumatology|October 1, 1986
Natural killer cell function in rheumatoid arthritisP E Lipsky
Pageof 43

Showing results (1-10 of 427) with videos related to

Sort By:
Pageof 43
The Journal of Rheumatology. Supplement|May 4, 1999
Specific COX-2 inhibitors in arthritis, oncology, and beyond: where is the science headed?P E Lipsky
Agents and Actions. Supplements|January 1, 1981
Modulation of T lymphocyte function by copper and thiolsP E Lipsky
American Journal of Orthopedics (Belle Mead, N.J.)|April 8, 1999
Role of cyclooxygenase-1 and -2 in health and diseaseP E Lipsky
Zeitschrift Fur Rheumatologie|January 1, 1988
Suggested mode of action of D-penicillamine as an immunosuppressive agent in rheumatoid arthritisP E Lipsky
The Journal of Rheumatology. Supplement|January 1, 1981
Modulation of human antibody production in vitro by D-penicillamine and CuSO4: inhibition of helper T cell functionP E Lipsky
Research in Immunology|May 1, 1990
The induction of human B-cell activation, proliferation and differentiation by anti-CD3-stimulated T cells--a model of T cell/B cell collaborationP E Lipsky
The Journal of Clinical Investigation|January 1, 1984
Immunosuppression by D-penicillamine in vitro. Inhibition of human T lymphocyte proliferation by copper- or ceruloplasmin-dependent generation of hydrogen peroxide and protection by monocytesP E Lipsky
Clinical and Experimental Rheumatology|September 1, 1989
Mechanisms of action of slow-acting drugs in rheumatoid arthritisP E Lipsky
Ryumachi. [Rheumatism]|December 1, 1987
Disease-modifying agents in rheumatoid arthritisP E Lipsky
Clinical and Experimental Rheumatology|October 1, 1986
Natural killer cell function in rheumatoid arthritisP E Lipsky
Pageof 43